Human pancreatic cancer-associated stellate cells remain activated after in vivo chemoradiation

by Marina Carla Cabrera, Marina Carla Cabrera, Estifanos eTilahun, Rebecca eNakles, Edgar eDiaz-Cruz, Edgar eDiaz-Cruz, Aline eCharabaty, Simeng eSuy, Simeng eSuy, Patrick eJackson, Lisa eLey, Rebecca eSlack, Reena eJha, Sean P Collins, Sean P Collins, Nadim eHaddad, Bhaskar V.S. Kallakury, Bhaskar V.S. Kallakury, Timm eSchroeder, Michael J Pishvaian, Michael J Pishvaian, Michael J Pishvaian, Priscilla A Furth, Priscilla A Furth
Published 2014-05-01

Genetic Drivers of Pancreatic Cancer Are Identical Between the Primary Tumor and a Secondary Lesion in a Long-Term (>5 Years) Survivor After a Whipple Procedure

by Tyler M. Bauer, Teena Dhir, Adam Strickland, Henry Thomsett, Austin B. Goetz, Shawnna Cannaday, Jonathan R. Brody, Michael J. Pishvaian, Charles J. Yeo
Published 2018-11-01

A Pilot Trial of Molecularly Tailored Therapy for Patients with Metastatic Pancreatic Ductal Adenocarcinoma

by Anteneh A. Tesfaye, Hongkun Wang, Marion L. Hartley, Aiwu Ruth He, Louis Weiner, Nina Gabelia, Lana Kapanadze, Muhammad Shezad, Jonathan R. Brody, John L. Marshall, Michael J. Pishvaian
Published 2019-05-01

A phase I trial of the mTOR inhibitor temsirolimus in combination with capecitabine in patients with advanced malignancies

by Neel D. Trivedi, Samantha Armstrong, Hongkun Wang, Marion Hartley, John Deeken, A. Ruth He, Deepa Subramaniam, Heather Melville, Chris Albanese, John L. Marshall, Jimmy Hwang, Michael J. Pishvaian
Published 2021-03-01

A phase Ib study of utomilumab (PF-05082566) in combination with mogamulizumab in patients with advanced solid tumors

by Ezra E. W. Cohen, Michael J. Pishvaian, Dale R. Shepard, Ding Wang, Jared Weiss, Melissa L. Johnson, Christine H. Chung, Ying Chen, Bo Huang, Craig B. Davis, Francesca Toffalorio, Aron Thall, Steven F. Powell
Published 2019-12-01